狠狠色丁香久久综合婷婷亚洲成人福利在线-欧美日韩在线观看免费-国产99久久久久久免费看-国产欧美在线一区二区三区-欧美精品一区二区三区免费观看-国内精品99亚洲免费高清

            深圳遠揚化學技術(shù)有限公司
            中級會員 | 第10年

            15012456311

            當前位置:深圳遠揚化學技術(shù)有限公司>>藥物雜質(zhì)對照品>>雜質(zhì)對照品>> Tofacitinib Impurity托法替尼雜質(zhì)提供結(jié)構(gòu)確認

            托法替尼雜質(zhì)提供結(jié)構(gòu)確認

            參   考   價: 100

            訂  貨  量: ≥1 

            具體成交價以合同協(xié)議為準

            產(chǎn)品型號Tofacitinib Impurity

            品       牌其他品牌

            廠商性質(zhì)生產(chǎn)商

            產(chǎn)品資料查看pdf文檔

            所  在  地深圳市

            更新時間:2017-02-23 17:08:04瀏覽次數(shù):1554次

            聯(lián)系我時,請告知來自 化工儀器網(wǎng)
            同類優(yōu)質(zhì)產(chǎn)品更多>
            托法替尼雜質(zhì)提供結(jié)構(gòu)確認 可提供NMR,HPLC,MS圖譜及COA證書,新藥申報可用全部雜質(zhì)現(xiàn)貨供應(yīng),*,并可接受定制。25mg/50mg/100mg等多種規(guī)格可選。

            托法替尼雜質(zhì)提供結(jié)構(gòu)確認  產(chǎn)品介紹:
            用途:實驗研發(fā),藥品申報檢測,不得用于臨床醫(yī)學診斷。
            隨貨提供:所有雜質(zhì)對照品均隨貨提供HPLC,NMR,MS圖譜及CoA證書。

             

            產(chǎn)品信息請:何      

            國產(chǎn)進口品牌皆有銷售,產(chǎn)品庫時常更新,部分雜質(zhì)長期備有庫存,可當天發(fā)貨,另外,我司有專業(yè)研發(fā)團隊,可提供雜質(zhì)定制服務(wù),以zui大可能的滿足您對雜質(zhì)對照品的選購需求。

             

            托法替尼雜質(zhì)提供結(jié)構(gòu)確認  雜質(zhì)列表:

            Tofacitinib

            3-((3R,4R)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanenitrile

            Tofacitinib Impurity 1

            N-((3R,4R)-1-benzyl-4-methylpiperidin-3-yl)-N-methyl-1H-indol-4-amine

            Tofacitinib Impurity 2

            2-chloro-N-methyl-N-((3R,4R)-4-methylpiperidin-3-yl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine

            Tofacitinib Impurity 3

            3-((3R,4R)-3-((2-chloro-7H-pyrrolo[2,3-d]pyrimidin-4-yl)(methyl)amino)-4-methylpiperidin-1-yl)-3-oxopropanenitrile

            Tofacitinib Impurity 4

            3-((3R,4R)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-2-yl)amino)piperidin-1-yl)-3-oxopropanenitrile

            Tofacitinib Impurity 5

            3-((3R,4R)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxoprop*

            Tofacitinib Impurity 6

            3-((3R,4R)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanoic acid

            Tofacitinib Impurity 7

            N-((3R,4R)-1-benzyl-4-methylpiperidin-3-yl)-2-chloro-N-methyl-7H-pyrrolo[2,3-d]pyrimidin-4-amine

            Tofacitinib Impurity 8

            N-methyl-N-((3R,4R)-4-methylpiperidin-3-yl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine hydrochloride

            Tofacitinib Impurity 9

            3-((3R,4S)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanenitrile compound with 3-((3S,4R)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanenitrile (1:1)

            Tofacitinib Impurity 10

            3-((3S,4S)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanenitrile

            Tofacitinib Impurity 11

            (3R,4S)-1-benzyl-N,4-dimethylpiperidin-3-amine dihydrochloride

            Tofacitinib Impurity 12

            (3S,4R)-1-benzyl-N,4-dimethylpiperidin-3-amine dihydrochloride

            Tofacitinib Impurity 13

            (3S,4S)-1-benzyl-N,4-dimethylpiperidin-3-amine dihydrochloride

            Tofacitinib Impurity 14

            (3R,4R)-1-benzyl-N,4-dimethylpiperidin-3-amine dihydrochloride

            Tofacitinib Impurity 15

            3-((3R,4R)-3-(7H-[4,7'-bipyrrolo[2,3-d]pyrimidin]-4'-yl(methyl)amino)-4-methylpiperidin-1-yl)-3-oxopropanenitrile

            Tofacitinib Impurity 16

            (3R,4R)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidine-1-carbaldehyde

            Tofacitinib Impurity 17

            N-methyl-N-((3R,4R)-4-methyl-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)piperidin-3-yl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine

            Tofacitinib Impurity 18

            3,3'-((3R,3'R,4R,4'R)-3,3'-((7H-pyrrolo[2,3-d]pyrimidine-2,4-diyl)bis(methylazanediyl))bis(4-methylpiperidine-3,1-diyl))bis(3-oxopropanenitrile)

            Tofacitinib Impurity 19

            3-(4-(((3R,4R)-1-(2-cyanoacetyl)-4-methylpiperidin-3-yl)(methyl)amino)-7H-pyrrolo[2,3-d]pyrimidin-7-yl)-3-oxopropanenitrile

            Tofacitinib Impurity 20

            3-((3R,4R)-3-((6,7-dihydro-5H-pyrrolo[2,3-d]pyrimidin-4-yl)(methyl)amino)-4-methylpiperidin-1-yl)-3-oxopropanenitrile

            Tofacitinib Impurity 21

            N-((3R,4R)-1-(2-cyanoacetyl)-4-methylpiperidin-3-yl)-N-methyl-7H-pyrrolo[2,3-d]pyrimidin-4-amine oxide

            Tofacitinib Impurity 22

            (3R,4R)-1-(2-chloro-7H-pyrrolo[2,3-d]pyrimidin-4-yl)-N,4-dimethylpiperidin-3-amine hydrochloride

            Tofacitinib Impurity 23

            (3R,4R)-N,4-dimethyl-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)piperidin-3-amine

            Tofacitinib Impurity 24

            N-((3R,4R)-1,4-dimethylpiperidin-3-yl)-N-methyl-7H-pyrrolo[2,3-d]pyrimidin-4-amine hydrochloride

            Tofacitinib Impurity 25

            1-((3R,4R)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)ethanone

            Tofacitinib Impurity 26

            N-((3R,4S)-1-benzyl-4-methylpiperidin-3-yl)-N-methyl-7-tosyl-7H-pyrrolo[2,3-d]pyrimidin-4-amine compound with N-((3S,4R)-1-benzyl-4-methylpiperidin-3-yl)-N-methyl-7-tosyl-7H-pyrrolo[2,3-d]pyrimidin-4-amine (1:1)

            Tofacitinib Impurity 27

            N-((3R,4R)-1-benzyl-4-methylpiperidin-3-yl)-N-methyl-7-tosyl-7H-pyrrolo[2,3-d]pyrimidin-4-amine

             

            更多關(guān)于   的信息,歡迎詳詢我司

            會員登錄

            ×

            請輸入賬號

            請輸入密碼

            =

            請輸驗證碼

            收藏該商鋪

            X
            該信息已收藏!
            標簽:
            保存成功

            (空格分隔,最多3個,單個標簽最多10個字符)

            常用:

            提示

            X
            您的留言已提交成功!我們將在第一時間回復(fù)您~
            撥打電話
            在線留言